Shire launches Fosrenol in United Kingdom
BASINGSTOKE, England, Feb. 22 (UPI) — Shire said Thursday it launched Fosrenol in the United Kingdom for the treatment of patients with chronic kidney disease.
The drug is approved in the United Kingdom for controlling hyperphosphatemia in patients on hemodialysis or continuous ambulatory peritoneal dialysis.
“Shire is delighted to launch Fosrenol in the UK where […]










Link